FDA-Inspected Site

East Marietta Drug Company

1 FDA inspection is on record for East Marietta Drug Company in Marietta, United States.

483· Form 483 issued

Marietta, United States · Last updated July 11, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2019-08-23.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
19 Aug 2019 – 23 Aug 2019Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

23 Aug 2019
FDCA 501(a)(2)(A)

Highly potent drugs, prevention of cross-contamination

Cited by Gideon N Esuzor, Johnetta F Walters

23 Aug 2019
FDCA 501(a)(2)(A)

Non-microbial contamination, production area

Cited by Gideon N Esuzor, Johnetta F Walters

23 Aug 2019
FDCA 501(a)(2)(A)

Personnel habits, contamination

Cited by Gideon N Esuzor, Johnetta F Walters

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations3x

Full site report

Get the verbatim findings behind East Marietta Drug Company's 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat